News section
home news forum careers events suppliers solutions markets resources directories advertise contacts search site plan
 
.
India may turn into a big producer of GM rice and vegetables by 2010

.

Chennai, India
January 24, 2008

Source: The Hindu Business Line via SEAMEO SEARCA

India has the potential to become a major producer of transgenic rice and several genetically modified (GM) or engineered vegetables by 2010, according to a research report by Rabo India Finance Ltd on the Indian agri-biotech sector. It has emerged as one of the leading destinations for investment in biotechnology in the recent years. It is also emerging as an important destination for both biomarkers and validation services, the report said.

A biomarker is a substance used as an indicator of a biologic state. It is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.

According to the report, there is an increasing use of molecular markers in crop breeding and a growing realisation that some of these new technologies could lead to future growth in the productivity and quality of crops such as rice, wheat, eggplant (brinjal), tomato and okra (lady's finger).

Stating that alliances were becoming increasingly important in seed industry to bridge the gap between field experience and emerging technologies, the report said most research and development works in the country are being done in the public sector. "These institutions are being generously funded by the Union Government," it said.

Research work on
Research work is being carried in 19 crops. They are rice, wheat, cotton, potato, banana, tomato, rapeseed, mustard, coffee, tobacco, eggplant, cabbage, cauliflower, melon, citrus fruit, black gram, groundnut, chickpea and pigeon pea.

Eight institutions, as per the report, are concentrating on two or more crops, while others are concentrating on one each.

"Four kinds of tracts are being tackled: Resistance to attacks by insect pests, viral and fungal diseases (biotic stress); drought tolerance, water logging and salinity; and delayed ripening and increasing shelf life," the report said.

Referring to Bt cotton, it said over 60 per cent of the 62 lakh hectares under hybrid seeds were GM strains, and a study had revealed gain to the tune of Rs 11,000 a hectare.

On Bt brinjal, the report said it could be the next important biotech crop with several public institutions and private companies developing improved varieties of drought tolerant ones. These plants are also being developed to resist shoot and fruit borer, it said, adding that two private firms have developed strains to control fruit and shoot borer.

While transgenic tomato is aimed at curbing damage from leaf curl virus and other infections such as buck eye rot of fruits, septoria and early blight, transgenic potato, being developed by public institutions, was yet to attract the private sector's attention. "On the regulatory front, it is in the final stages of approval (by the Genetic Engineering Approval Committee)," the report said.

GM strains
Stating that much attention was being paid to research on GM rice, Rabo India said the aim was to develop saline and drought tolerant varieties, but no GM strain had been commercially released. However, developments relating to the "Golden" rice will have a significant impact on India, it said.

GM wheat was under development at the South Campus of the Delhi University, while a host of other crops were being developed by public and private sector.

"The future of transgenic seeds will see many private companies entering into the transgenic seed market in India. Many companies are developing agronomically important crops. Some medium and large size seed companies with an annual turnover of Rs 35 crore are developing transgenic seeds," it said.

On the challenges faced by the industry, the report said intellectual property was one of the deterrents to growth of the biotech industry as foreign players feel there was no sufficient patent protection and access to patent litigation in the country. "However, this perception has recently changed to a great extent," it said.

On the biotech sector's growth, the Rabo India said during 2006-07, the agri-biotech industry's revenue was Rs 926 crore, while it clocked an annual growth of 55 per cent.

 

 

 

 

The news item on this page is copyright by the organization where it originated - Fair use notice

Other news from this source


Copyright © SeedQuest - All rights reserved